Atara Biotherapeutics

$24.59
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.78 (+3.28%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ATRA and other stocks, options, and ETFs commission-free!

About ATRA

Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. The listed name for ATRA is Atara Biotherapeutics, Inc. Common Stock.

CEO
Pascal Touchon
Employees
393
Headquarters
South San Francisco, California
Founded
2012
Market Cap
1.91B
Price-Earnings Ratio
Dividend Yield
Average Volume
770.24K
High Today
$24.82
Low Today
$23.44
Open Price
$23.86
Volume
733.25K
52 Week High
$24.82
52 Week Low
$4.52

Collections

ATRA Earnings

-$1.60
-$1.07
-$0.53
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Feb 25, After Hours

You May Also Like